Darshan Singh

Darshan Singh

Author is a pharmaceutical professional who is Master in Science (Organic Chemistry) and Diploma in Pharmacy. He has rich experience in pharma manufacturing sector, He Served in many companies as Quality Control Head, and Quality Assurance Head, along with Plant Head supervised all manufacturing processes. He is keen to research of pharma product manufacturing and drugs pharmacology. He is writing on several topics about pharmaceutical products, processes, and SOPs.

DAWNZERA (donidalorsen) FDA Approval & HAE Prophylaxis

DAWNZERA (donidalorsen)

DAWNZERA (donidalorsen) is an FDA-approved antisense oligonucleotide indicated for prophylaxis of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. Approved on 2025-08-21, DAWNZERA targets prekallikrein mRNA, reducing bradykinin production, the key mediator of angioedema attacks. In…